Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	BMYBristol Myers Squibb	GSKGSK plc	PFEPfizer
Snapshot
Price	$67.31	$50.44	$28.98
Market cap	$118.71B	$102.51B	$138.61B
Valuation
P/E	23x	13.8x	22x
Forward P/E	18.2x	9.8x	23.2x
Growth
Revenue growth	1.8%	4.0%	1.4%
EPS growth	26.3%	86.7%	-5.3%
Profitability
Net margin	12.3%	17.8%	11.8%
ROE	41.6%	35.8%	8.4%
Balance sheet & cash
Debt / equity	2.44x	1.08x	0.75x
Free cash flow yield	15.4%	3.8%	11.2%
Dividend yield	4.5%	3.5%	6.6%
Verdict
Investment rating	Favorable· 60	Favorable· 66	Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	BMYtoday $67	GSKtoday $50	PFEtoday $29
2027	$63.74 – $93.49+39% CAGR	$70.64 – $103.61+105% CAGR	$22.17 – $32.52+12% CAGR
2028	$80.49 – $118.05+32% CAGR	$131.91 – $193.46+96% CAGR	$22.61 – $33.17+7% CAGR
2029	$101.63 – $149.06+30% CAGR	$246.31 – $361.25+93% CAGR	$23.07 – $33.83+5% CAGR
2030	$128.33 – $188.22+29% CAGR	$459.93 – $674.57+91% CAGR	$23.53 – $34.51+4% CAGR
2031	$162.05 – $237.67+29% CAGR	$858.83 – $1,259.62+90% CAGR	$24.00 – $35.20+4% CAGR
5-yr CAGR	19.2% – 28.7%	76.3% – 90.3%	-3.7% – 4.0%